Clinical Implementations of Pharmacogenomics

pmc


Please note we are unable to grant Continuing Pharmacy Education credit to students who attended the live Precision Medicine Conference 2017.

 

Intended Audience
Pharmacist

Presenters
Mark Dunnenberger, Pharm.D.
Director of Pharmacogenomics, Center for Molecular Medicine
NorthShore University Health System

Kristin Weitzel, Pharm.D., CDE, FAPhA
Associate Director, UF Health Personalized Medicine Program
Director, Continuing Pharmacy Education
Editor-in-Chief, Pharmacy Today
Clinical Professor, Pharmacotherapy and Translational Research
University of Florida

Megan Arwood, Pharm.D., BCPS
Clinical Assistant Professor
Department of Pharmacotherapy and Translational Research
University of Florida

Victoria Pratt Ph.D., FACM
Associate Professor of Clinical Medicine
Director, Pharmacogenomics and Molecular Genetics Laboratories
Indiana University

James Hoffman, Pharm.D.
Associate Member, St. Jude Faculty
Chief Patient Safety Officer
Director, Medication-Use Safety Residency Program
St. Jude Children’s Research Hospital

ACPE University Activity Number
0012-0000-17-317-H04-P

CE Hours
2.5

Price
$75.00

Dates Available
01/01/2018 – 01/01/2021

Activity Type
Knowledge

 

Summary

This course will summarize how to develop a clinical pharmacogenetic service, test and reimburse for pharmacogenetic results, and design electronic and written documentation.

Objectives

Laboratory Testing in Clinical Pharmacogenetics: How to Choose a Commercial Laboratory

  • Compare and contrast approaches to clinical laboratory testing in pharmacogenomics.
  • Explain practice-based differences between panel-based testing as compared with testing individual genes for pharmacogenetic recommendations.
  • List criteria for evaluating commercial pharmacogenetic testing laboratories.
  • Identify essential information needed when interpreting commercial laboratory reports in pharmacogenetics.

Advancing Clinical Implementation of Pharmacogenetics: Progress, Needs, and Opportunities

  • Summarize current national landscape and trends for clinical pharmacogenetics implementation in various practice settings.
  • Compare approaches to genetic testing and patient care that may be used in clinical implementation.
  • List steps for developing a new clinical pharmacogenetics patient care service.
  • Identify factors that influence the successful development of clinical pharmacogenetics services.

Clinical Laboratory Testing and Reimbursement in Pharmacogenetics

  • Describe laboratory testing and reimbursement models for pharmacogenetic testing.
  • Compare and contrast various strategies and methods for pharmacogenetic testing and reimbursement in clinical practice.
  • Summarize reimbursement challenges in precision medicine and strategies for overcoming these challenges.
  • Determine appropriate use of CPT coding for pharmacogenetic testing.

Electronic and Written Documentation in Clinical Pharmacogenetics: How, When, and Why?

  • Discuss the role of electronic health record in implementing clinical pharmacogenetics.
  • Summarize current initatives to improve integration of genomic data into electronic health record.
  • Identify barriers to implementing changes to the electronic health record in pharmacogenetics implementation and strategies to overcome these barriers in practice.

Schedule of Activities

View the recorded lectures and complete a post-test.

Requirements for Successful Course Completion

View recorded lectures, receive a 70% or higher on final exam and complete course evaluation.

Program Financial Support

This course received no outside funding support.

Acknowledgement and Disclosures

Kristin Weitzel, Pharm.D., CDE, FAPhA has disclosed that she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.

Megan Arwood, Pharm.D., BCPS has disclosed that she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.

Mark Dunnenberger, Pharm.D. has disclosed he is a consultant for Admera Health and Veritas Genetics.  No one else in a position to control content has any financial relationships to disclose

James Hoffman, Pharm.D. has disclosed that he has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.


Computer Requirements

Computer and Internet access are required to complete this course. Course content is provided via Canvas.

The minimum hardware, software, and Internet requirements for Canvas can be found here.

Policies

Refund Policy for CE Courses
Information Privacy Statement

Reporting Credit

The University of Florida College of Pharmacy will report credit to CPE Monitor and CE Broker when applicable. If you would like a paper statement of credit, you may print it from your NABP e-profile.

Copyright

This course  in its entirety is copyrighted by the University of Florida Continuing Pharmacy Education and may not be duplicated or reproduced for any other purpose without specific written permission.

Contact Information

For questions or more information, please contact our office.


ACPE LogoThe University of Florida College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.